サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1177595

臨床試験の世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測

Global Clinical Trials Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028
出版日: | 発行: Value Market Research | ページ情報: 英文 266 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
臨床試験の世界市場調査レポート-産業分析、規模、シェア、成長、動向、2022年から2028年までの予測
出版日: 2022年12月01日
発行: Value Market Research
ページ情報: 英文 266 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Value Market Research社は、世界の臨床試験市場を深く調査し、今後数年間の業界の大きな成長を予見しています。世界の臨床試験市場レポートでは、完全な業界分析、市場規模、市場シェア、成長動向、2023年から2028年までの予測などを提供しています。本レポートは、詳細な市場イントロダクションと、レポートの主な成長数値にハイライトを当てたエグゼクティブサマリーから始まります。続く章では、市場のバリューチェーン、ポーターのファイブフォースモデル、市場の魅力度分析について論じています。また、COVID-19の影響分析に関する独自の章を設け、市場がパンデミックにどのように対応してきたかを理解していきます。

本レポートの市場力学のセクションでは、現在の市場の促進要因・抑制要因、課題・リスク、今後の機会について詳しく説明しています。このセクションは、企業の戦略担当者や新製品開発部門にとって非常に有益なものとなるでしょう。世界の臨床試験市場の調査では、市場をセグメント化し、収益および/または売上高で市場規模を提供します。このデータは地域別、後に国別に細分化されています。データは、世界中の詳細な一次インタビューや業界専門家を通じて収集されています。詳細な調査手法は、サンプルレポートでご覧いただけます。これらの市場予測は、この臨床試験市場に影響を与える現在の市場力学とともに、最新の社会的、政治的、経済的変化にも影響されます。

臨床試験市場レポートの次のセクションでは、市場競争力を調査し、いくつかの主要な市場プレーヤー/メーカーをプロファイルします。これらのセクションは、競合他社の製品ライン、財務、最近の市場開拓、業界におけるトップシェアの所有者を理解するために知識豊富です。

目次

第1章 序文

  • 当レポートの内容
    • 目的
    • 対象読者
    • ユニークセリング・プロポジション（USP）および提供サービス
  • 調査範囲
  • 調査手法
    • 市場調査プロセス
    • 市場調査手法

第2章 エグゼクティブサマリー

  • 臨床試験市場のハイライト
  • 世界の臨床試験市場のスナップショット

第3章 臨床試験- 産業分析

  • イントロダクション
  • 臨床試験市場の市場促進要因
  • 臨床試験市場の市場抑制要因
  • 臨床試験市場の機会
  • 臨床試験市場の動向
  • 臨床試験市場のポーターのファイブフォース分析
  • 臨床試験市場の魅力度分析
    • フェーズ別市場魅力度分析
    • 試験デザイン別市場魅力度分析
    • 市場魅力度分析：適応症別
    • 市場魅力度分析：地域別

第4章 バリューチェーン分析

  • 臨床試験のバリューチェーン分析
  • 臨床試験の原材料分析
    • 原材料のリスト
    • 臨床試験原材料の製造元リスト
    • 臨床試験の主要原材料の価格動向
  • 潜在的なバイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • 間接マーケティング
    • マーケティングチャネル開拓動向

第5章 臨床試験の世界市場分析：フェーズ別

  • フェーズ別概要
  • 世界の臨床試験市場のフェーズ別分析
  • フェーズIの市場分析：地域別
  • フェーズIIの市場分析：地域別
  • フェーズIIIの市場分析：地域別
  • フェーズIVの市場分析：地域別

第6章 世界の臨床試験市場の分析：試験デザイン別

  • 試験デザイン別概要
  • 世界の臨床試験市場分析：試験デザイン別
  • インターベンションの市場分析：地域別
  • 研究の市場分析：地域別
  • 拡大アクセスの市場分析：地域別

第7章 世界の臨床試験市場分析：適応症別

  • 適応症別概要
  • 世界の臨床試験市場の分析：適応症別
  • 自己免疫/炎症の市場分析：地域別
  • 疼痛管理の市場分析：地域別
  • 腫瘍の市場分析：地域別
  • 中枢神経系疾患の市場分析：地域別
  • 糖尿病の市場分析：地域別
  • 肥満の市場分析：地域別
  • 循環器の市場分析：地域別

第8章 臨床試験の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米
    • 概要
    • 北米の臨床試験市場推定：国別
    • 米国
    • その他北米地域
  • 欧州
    • 概要
    • 欧州の臨床試験市場の予測：市場セグメント別
    • 欧州臨床試験市場予測：国別
    • 英国
    • フランス
    • ドイツ
    • その他の欧州地域
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の臨床試験市場の予測：市場セグメント別
    • アジア太平洋地域の臨床試験市場の予測：国別
    • 中国
    • 日本
    • インド
    • その他アジア太平洋地域
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの臨床試験市場の予測：市場セグメント別
    • ラテンアメリカの臨床試験市場予測：国別
    • ブラジル
    • その他のラテンアメリカ地域
  • 中東&アフリカ
    • 概要
    • 中東・アフリカの臨床試験市場の予測：市場セグメント別
    • 中東・アフリカの臨床試験市場予測：国別
    • 中東地域
    • アフリカ

第9章 臨床試験企業の競合情勢

  • 臨床試験市場競争
  • パートナーシップ／コラボレーション／アグリーメント
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Charles River Laboratories
    • 企業概要
    • 製品紹介
    • 最近の開発状況
  • ICON plc
    • 会社概要
    • 製品紹介
    • 最近の開発状況
  • Paraxel International Corporation
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • Quintiles IMS
    • 会社概要
    • 製品情報
    • 最近の開発状況
  • SGS SA
    • 会社概要
    • 製品情報
    • 最近の動向
  • その他
    • 会社概要
    • 製品情報
    • 最近の開発状況

第11章 COVID-19の発生による影響分析

  • COVID-19の発生が市場に与える影響分析
    • 生産への直接的な影響
    • サプライチェーンと市場の混乱
    • 企業および金融市場への財務的影響
  • COVID-19の生産、輸入、輸出、需要別の影響分析
  • COVID-19発生前後の市場推移
  • コロナウイルス（COVID-19）流行別2020年市場規模への影響予測：シナリオ別
  • COVID-19：市場に関するミクロおよびマクロ要因の分析

注：企業プロファイルにおいて、財務の詳細や最近の開発状況は入手可能であることが条件であり、非公開会社の場合はカバーされていない可能性があります。

図表

LIST OF TABLES

  • Global Market Snapshot
  • Drivers of the Global Market Impact Analysis
  • Restraints of the Global Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19 Market
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on the Market
  • Global Clinical Trials Market Analysis by Phase (USD MN)
  • Global Clinical Trials Market Analysis in Phase I by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase II by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase III by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase IV by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Study Design (USD MN)
  • Global Clinical Trials Market Analysis in Interventional by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Observational by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Expanded Access by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Indication (USD MN)
  • Global Clinical Trials Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Pain Management by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Oncology by Geography (USD MN)
  • Global Clinical Trials Market Analysis in CNS Condition by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Diabetes by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Obesity by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Cardiovascular by Geography (USD MN)
  • Global Clinical Trials Market by Geography (USD MN)
  • North America Clinical Trials Market Analysis by Phase (USD MN)
  • North America Clinical Trials Market Estimate by Study Design (USD MN)
  • North America Clinical Trials Market Estimate by Indication (USD MN)
  • North America Clinical Trials Market Estimate by Country (USD MN)
  • United State Clinical Trials Market Analysis by Phase (USD MN)
  • United State Clinical Trials Market Estimate by Study Design (USD MN)
  • United State Clinical Trials Market Analysis by Indication (USD MN)
  • Rest of North America Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of North America Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of North America Clinical Trials Market Estimate by Indication(USD MN)
  • Europe Clinical Trials Market Analysis by Phase (USD MN)
  • Europe Clinical Trials Market Estimate by Study Design (USD MN)
  • Europe Clinical Trials Market Estimate by Indication (USD MN)
  • United Kingdom Clinical Trials Market Analysis by Phase (USD MN)
  • United Kingdom Clinical Trials Market Estimate by Study Design (USD MN)
  • United Kingdom Clinical Trials Market Estimate by Indication (USD MN)
  • France Clinical Trials Market Analysis by Phase (USD MN)
  • France Clinical Trials Market Estimate by Study Design (USD MN)
  • France Clinical Trials Market Estimate by Indication (USD MN)
  • Germany Clinical Trials Market Analysis by Phase (USD MN)
  • Germany Clinical Trials Market Estimate by Study Design (USD MN)
  • Germany Clinical Trials Market Estimate by Indication (USD MN)
  • Rest of Europe Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of Europe Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of Europe Clinical Trials Market Estimate by Indication (USD MN)
  • Asia Pacific Clinical Trials Market Analysis by Phase (USD MN)
  • Asia Pacific Clinical Trials Market Estimate by Study Design (USD MN)
  • Asia Pacific Clinical Trials Market Estimate by Indication (USD MN)
  • Asia Pacific Clinical Trials Market Estimate by Country (USD MN)
  • China Clinical Trials Market Analysis by Phase (USD MN)
  • China Clinical Trials Market Estimate by Study Design (USD MN)
  • China Clinical Trials Market Estimate by Indication (USD MN)
  • Japan Clinical Trials Market Analysis by Phase (USD MN)
  • Japan Clinical Trials Market Estimate by Study Design (USD MN)
  • Japan Clinical Trials Market Estimate by Indication (USD MN)
  • India Clinical Trials Market Analysis by Phase (USD MN)
  • India Clinical Trials Market Estimate by Study Design (USD MN)
  • India Clinical Trials Market Estimate by Indication (USD MN)
  • Rest of Asia Pacific Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of Asia Pacific Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of Asia Pacific Clinical Trials Market Estimate by Indication (USD MN)
  • Latin America Clinical Trials Market Analysis by Phase (USD MN)
  • Latin America Clinical Trials Market Estimate by Study Design (USD MN)
  • Latin America Clinical Trials Market Estimate by Indication (USD MN)
  • Latin America Clinical Trials Market Estimate by Country (USD MN)
  • Brazil Clinical Trials Market Analysis by Phase (USD MN)
  • Brazil Clinical Trials Market Estimate by Study Design (USD MN)
  • Brazil Clinical Trials Market Estimate by Indication (USD MN)
  • Rest of Latin America Clinical Trials Market Analysis by Phase (USD MN)
  • Rest of Latin America Clinical Trials Market Estimate by Study Design (USD MN)
  • Rest of Latin America Clinical Trials Market Estimate by Indication (USD MN)
  • Middle East & Africa Clinical Trials Market Analysis by Phase (USD MN)
  • Middle East & Africa Clinical Trials Market Estimate by Study Design (USD MN)
  • Middle East & Africa Clinical Trials Market Estimate by Indication (USD MN)
  • Middle East & Africa Clinical Trials Market Estimate by Country (USD MN)
  • Middle East Clinical Trials Market Analysis by Phase (USD MN)
  • Middle East Clinical Trials Market Estimate by Study Design (USD MN)
  • Middle East Clinical Trials Market Estimate by Indication (USD MN)
  • Africa Clinical Trials Market Analysis by Phase (USD MN)
  • Africa Clinical Trials Market Estimate by Study Design (USD MN)
  • Africa Clinical Trials Market Estimate by Indication (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis

LIST OF FIGURES

  • Research Scope of Clinical Trials Report
  • Market Research Process
  • Market Research Methodology
  • Global Clinical Trials Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Phase
  • Market Attractiveness Analysis by Study Design
  • Market Attractiveness Analysis by Indication
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Clinical Trials Market Analysis by Phase (USD MN)
  • Global Clinical Trials Market Analysis in Phase I by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase II by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase III by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Phase IV by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Study Design (USD MN)
  • Global Clinical Trials Market Analysis in Interventional by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Observational by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Expanded Access by Geography (USD MN)
  • Global Clinical Trials Market Analysis by Indication (USD MN)
  • Global Clinical Trials Market Analysis in Autoimmune/Inflammation by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Pain Management by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Oncology by Geography (USD MN)
  • Global Clinical Trials Market Analysis in CNS Condition by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Diabetes by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Obesity by Geography (USD MN)
  • Global Clinical Trials Market Analysis in Cardiovascular by Geography (USD MN)
  • Latin America Clinical Trials Market by Revenue
  • Middle East & Africa Clinical Trials Market by Revenue
  • Recent Development in Clinical Trials Industry
  • Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11210536

Value Market Research deeply researched the Global Clinical Trials Market to foresee a significant growth in the industry over the upcoming years. The global clinical trials market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global clinical trials market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this clinical trials market.

The next sections of the clinical trials market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Phase

Phase I

Phase II

Phase III

Phase IV

By Study Design

Interventional

Observational

Expanded Access

By Indication

Autoimmune/Inflammation

Pain Management

Oncology

CNS Condition

Diabetes

Obesity

Cardiovascular

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Clinical Trials Market
  • 2.2. Global Clinical Trials Market Snapshot

3 . CLINICAL TRIALS - INDUSTRY ANALYSIS

  • 3.1. Introduction
  • 3.2. Market Drivers of Clinical Trials Market
  • 3.3. Market Restraints of Clinical Trials Market
  • 3.4. Opportunities of Clinical Trials Market
  • 3.5. Trends of Clinical Trials Market
  • 3.6. Porter's Five Force Analysis of Clinical Trials Market
  • 3.7. Clinical Trials Market Attractiveness Analysis
    • 3.7.1 Market Attractive Analysis by Phase
    • 3.7.2 Market Attractive Analysis by Study Design
    • 3.7.3 Market Attractive Analysis by Indication
    • 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Clinical Trials Value Chain Analysis
  • 4.2. Clinical Trials Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Clinical Trials Raw Material Manufactures List
    • 4.2.3. Price Trend of Clinical Trials Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY PHASE

  • 5.1 Overview by Phase
  • 5.2 Global Clinical Trials Market Analysis by Phase
  • 5.3 Market Analysis of Phase I by Regions
  • 5.4 Market Analysis of Phase II by Regions
  • 5.5 Market Analysis of Phase III by Regions
  • 5.6 Market Analysis of Phase IV by Regions

6 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY STUDY DESIGN

  • 6.1 Overview by Study Design
  • 6.2 Global Clinical Trials Market Analysis by Study Design
  • 6.3 Market Analysis of Interventional by Regions
  • 6.4 Market Analysis of Observational by Regions
  • 6.5 Market Analysis of Expanded Access by Regions

7 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY INDICATION

  • 7.1 Overview by Indication
  • 7.2 Global Clinical Trials Market Analysis by Indication
  • 7.3 Market Analysis of Autoimmune/Inflammation by Regions
  • 7.4 Market Analysis of Pain Management by Regions
  • 7.5 Market Analysis of Oncology by Regions
  • 7.6 Market Analysis of CNS Condition by Regions
  • 7.7 Market Analysis of Diabetes by Regions
  • 7.8 Market Analysis of Obesity by Regions
  • 7.9 Market Analysis of Cardiovascular by Regions

8 . GLOBAL CLINICAL TRIALS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America
    • 8.3.1. Overview
    • 8.3.2. North America Clinical Trials Market Estimate by Country
    • 8.3.3. United State
    • 8.3.4. Rest of North America
  • 8.4. Europe
    • 8.4.1. Overview
    • 8.4.2. Europe Clinical Trials Market Estimate by Market Segment
    • 8.4.3. Europe Clinical Trials Market Estimate by Country
    • 8.4.4. United Kingdom
    • 8.4.5. France
    • 8.4.6. Germany
    • 8.4.7 Rest of Europe
  • 8.5. Asia Pacific
    • 8.5.1. Overview
    • 8.5.2. Asia Pacific Clinical Trials Market Estimate by Market Segment
    • 8.5.3. Asia Pacific Clinical Trials Market Estimate by Country
    • 8.5.4. China
    • 8.5.5. Japan
    • 8.5.6. India
    • 8.5.7. Rest of Asia Pacific
  • 8.6. Latin America
    • 8.6.1. Overview
    • 8.6.2. Latin America Clinical Trials Market Estimate by Market Segment
    • 8.6.3. Latin America Clinical Trials Market Estimate by Country
    • 8.6.4. Brazil
    • 8.6.5. Rest of Latin America
  • 8.7. Middle East & Africa
    • 8.7.1. Overview
    • 8.7.2. Middle East & Africa Clinical Trials Market Estimate by Market Segment
    • 8.7.3. Middle East & Africa Clinical Trials Market Estimate by Country
    • 8.7.4. Middle East
    • 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE CLINICAL TRIALS COMPANIES

  • 9.1. Clinical Trials Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CLINICAL TRIALS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Charles River Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Financials
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. ICON plc
    • 10.4.1. Company Overview
    • 10.4.2. Financials
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Paraxel International Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financials
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Quintiles IMS
    • 10.6.1. Company Overview
    • 10.6.2. Financials
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. SGS SA
    • 10.7.1. Company Overview
    • 10.7.2. Financials
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Others
    • 10.8.1. Company Overview
    • 10.8.2. Financials
    • 10.8.3. Products
    • 10.8.4. Recent Developments

11. IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 11.1. Impact Analysis of Covid-19 Outbreak on the Market
    • 11.1.1. Direct Impact on Production
    • 11.1.2. Supply Chain and Market Disruption
    • 11.1.3. Financial Impact on Firms and Financial Markets
  • 11.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 11.3. Pre V/S Post COVID-19 Market
  • 11.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
  • 11.5. COVID-19: Micro and Macro Factor Analysis on the Market

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies